Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus
- A H Sawalha1,2,3,
- K M Kaufman1,2,3,
- J A Kelly3,
- A J Adler3,
- T Aberle3,
- J Kilpatrick3,
- E K Wakeland4,
- Q-Z Li4,
- A E Wandstrat4,
- D R Karp5,
- J A James3,
- J T Merrill2,3,
- P Lipsky6,
- J B Harley1,2,3
- 1US Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, USA
- 2Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
- 3Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA
- 4Center for Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
- 5Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA
- 6Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA
- Amr H Sawalha, 825 N.E. 13th Street, MS#24, Oklahoma City, Oklahoma 73104, USA;
- Accepted 12 August 2007
- Published Online First 24 August 2007
Objective: The aetiology of systemic lupus erythematosus (SLE) is incompletely understood. Both genetic and environmental factors are implicated in the pathogenesis of the disease. Herein, we describe genetic association between SLE and polymorphisms in the interleukin (IL)-21 gene. The reported effect of IL-21 on B-cell differentiation into plasma cells and its effect on dendritic cell maturation and T-cell responses make IL-21 an attractive candidate gene for SLE.
Methods: Three single nucleotide polymorphisms (SNPs) in the IL-21 gene were genotyped in a total of 2636 individuals (1318 cases and 1318 controls matched for age, sex and race). Population-based case–control association analyses were performed.
Results: We found a genetic association with SLE and two SNPs located within the IL-21 gene (rs907715: χ2 = 11.55, p<0.001; rs2221903: χ2 = 5.49, p = 0.019). Furthermore, genotypes homozygous for the risk alleles were more frequent than genotypes homozygous for the non-risk alleles in European–American patients as compared to controls (rs907715 (GG versus AA): odds ratio (OR) = 1.66, p = 0.0049; rs2221903 (GG versus AA): OR = 1.60, p = 0.025).
Conclusion: Our findings indicate that IL-21 polymorphism is a candidate association with SLE. The functional effects of this association, when revealed, might improve our understanding of the disease and provide new therapeutic targets.
Funding: This publication was made possible by NIH Grant Number P20-RR015577 from the National Center for Research Resources and by funding from the University of Oklahoma College of Medicine (AHS); the NIH (AI24717, AI31584, AI053747, AR12253, AR42460, AR4894, and RR020143), the Alliance for Lupus Research, the Mary Kirkland Fellowship, and the US Department of Veterans Affairs (JBH).
Competing interests: None declared.